Your browser doesn't support javascript.
loading
Pretreatment Contrast-Enhanced Computed Tomography Radiomics for Prediction of Pathological Regression Following Neoadjuvant Chemotherapy in Locally Advanced Gastric Cancer: A Preliminary Multicenter Study.
Xie, Kun; Cui, Yanfen; Zhang, Dafu; He, Weiyang; He, Yinfu; Gao, Depei; Zhang, Zhiping; Dong, Xingxiang; Yang, Guangjun; Dai, Youguo; Li, Zhenhui.
Afiliación
  • Xie K; Department of Radiology, Yunnan Cancer Hospital, Yunnan Cancer Center, the Third Affiliated Hospital of Kunming Medical University, Kunming, China.
  • Cui Y; Department of Radiology, Shanxi Province Cancer Hospital, Shanxi Medical University, Taiyuan, China.
  • Zhang D; Department of Radiology, Yunnan Cancer Hospital, Yunnan Cancer Center, the Third Affiliated Hospital of Kunming Medical University, Kunming, China.
  • He W; Department of Gastrointestinal Surgery, Sichuan Province Cancer Hospital, University of Electronic Science and Technology of China, Chengdu, China.
  • He Y; Department of Radiology, Yunnan Cancer Hospital, Yunnan Cancer Center, the Third Affiliated Hospital of Kunming Medical University, Kunming, China.
  • Gao D; Department of Radiology, Yunnan Cancer Hospital, Yunnan Cancer Center, the Third Affiliated Hospital of Kunming Medical University, Kunming, China.
  • Zhang Z; Department of Radiology, Yunnan Cancer Hospital, Yunnan Cancer Center, the Third Affiliated Hospital of Kunming Medical University, Kunming, China.
  • Dong X; Department of Radiology, Yunnan Cancer Hospital, Yunnan Cancer Center, the Third Affiliated Hospital of Kunming Medical University, Kunming, China.
  • Yang G; Department of Radiology, Yunnan Cancer Hospital, Yunnan Cancer Center, the Third Affiliated Hospital of Kunming Medical University, Kunming, China.
  • Dai Y; Department of Gastric and Surgery, Yunnan Cancer Hospital, Yunnan Cancer Center, the Third Affiliated Hospital of Kunming Medical University, Kunming, China.
  • Li Z; Department of Radiology, Yunnan Cancer Hospital, Yunnan Cancer Center, the Third Affiliated Hospital of Kunming Medical University, Kunming, China.
Front Oncol ; 11: 770758, 2021.
Article en En | MEDLINE | ID: mdl-35070974

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Oncol Año: 2021 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Oncol Año: 2021 Tipo del documento: Article País de afiliación: China